# ANTEPAR
> **NDA009102** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1957-01-25
## Drug
- **FDA Application Number:** NDA009102
- **Application type:** New Drug Application
- **Brand name:** ANTEPAR
- **Generic name:** Piperazine Citrate
- **Active ingredients:** PIPERAZINE CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** GLAXOSMITHKLINE
- **First approval:** 1957-01-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=009102)
---
*MORVS · CC0 1.0*